Phase 2 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have had a diagnostic ultrasound performed at the University of North Carolina
- People who are already scheduled to have a biopsy
- People whose lesion (an area of concern) was visible on an ultrasound scan
- People who are able to give their informed consent to take part
- Women who could potentially become pregnant must have a negative urine pregnancy test before joining
Who may not be able to join:
- People who are currently living in a prison or nursing home
- People who are critically ill or medically unstable in a way that makes their condition hard to predict during the study period (for example, people with a serious lung condition such as COPD)
- People who have a known allergy or sensitivity to sulfur hexafluoride or to any ingredient in a contrast agent called Definity®
- People with severe heart failure that severely limits all physical activity (classified as Class IV by a standard heart health scale)
- People with unstable chest pain (unstable angina)
- People with serious irregular heart rhythms of certain types (confirm with trial site)
- People who have had a heart attack within the 14 days before they would receive the study agent Definity®
- People with high blood pressure in the lungs (pulmonary hypertension)
- People who have an abnormal opening or passage between the chambers or vessels of the heart (cardiac shunts)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yueh Lee, MD, UNC Lineberger Comprehensive Cancer Center
Phone: (919) 843-9463
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity of Contrast Enhanced Super-Resolution (CESR) breast imaging; Specificity of Contrast Enhanced Super-Resolution (CESR) breast imaging; Sensitivity of Contrast Enhanced Super-Resolution (CESR) kidney imaging; Specificity of Contrast Enhanced Super-Resolution (CESR) kidney imaging; Sensitivity of Contrast Enhanced Super-Resolution (CESR) liver imaging; Specificity of Contrast Enhanced Super-Resolution (CESR) liver imaging
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.